In addition, baicalin reduced the survival of peripheral blood leukocytes (PBLs) in individuals suffering from acute lymphoblastic leukemia (ALL), increased IFNγ production in PBLs and decreased the production of TNFα and IL-10 in bone marrow cells (BMCs) in ALL patients. The gene discussed is IL10; the disease is acute lymphoblastic leukemia.